Acadia Pharmaceuticals Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2009 | $-13.7M | $-13.7M | — | $2.1M |
| FY2010 | $-10.7M | $-10.7M | — | $1.6M |
| FY2011 | $-19.9M | $-19.9M | $3.0K | $1.6M |
| FY2012 | $-21.6M | $-21.6M | — | $1.9M |
| FY2013 | $-31.8M | $-32.4M | $618.0K | $5.7M |
| FY2014 | $-66.4M | $-66.6M | $180.0K | $16.0M |
| FY2015 | $-121.8M | $-123.9M | $2.1M | $40.2M |
| FY2016 | $-208.4M | $-209.9M | $1.5M | $55.3M |
| FY2017 | $-217.8M | $-218.6M | $812.0K | $75.5M |
| FY2018 | $-167.5M | $-169.6M | $2.1M | $81.6M |
| FY2019 | $-151.1M | $-152.3M | $1.1M | $82.3M |
| FY2020 | $-136.2M | $-143.8M | $7.6M | $84.4M |
| FY2021 | $-125.7M | $-126.8M | $1.1M | $63.6M |
| FY2022 | $-114.0M | $-114.0M | $0 | $68.2M |
| FY2023 | $16.7M | $16.7M | $50.0K | $66.4M |
| FY2024 | $157.7M | $157.2M | $523.0K | $67.0M |
| FY2025 | $109.8M | $105.1M | $4.7M | $52.1M |